Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Cohort entry was defined as the date of the first-ever prescription for one of the drugs of interest (GLP-1RAs, SGLT2 inhibitors, metformin or other second- or third-line glucose-lowering drugs) during the study period, and their respective first exposure was defined as the index event
Semaglutides single-action mechanism solely activates the GLP-1 receptor to regulate insulin and appetite
Effects of novel glucose-lowering drugs on the lipid parameters: a systematic review and meta-analysis
Mounjaro Tirzepatide Dual GLP-1 + GIP agonist
US$ 20.01
US$ 26.65
US$ 29.88
